Echoliv

Curated by Signal

AI-based liver cancer diagnosis tool for providers

Overview

AI-based liver cancer diagnosis tool for providers. The company has developed software that assists radiologists and hepatologists with disease diagnoses. It has features for early detection of cancer, report writing, telecommunication. data analysis and more.

Key facts

Founded: 2021
Headquarters: Paris, France
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

MadeCELL
Developer of software technology for gene therapy
Health TechnologyBois Colombes, France
ETISENSE
Developer of a wearable cardio-respiratory monitoring device
Health TechnologyLyon, France
Helpicto
Provider of an AI- based tool for communication for autism patients
Health TechnologyToulouse, France

About Echoliv

What does Echoliv do?

AI-based liver cancer diagnosis tool for providers.

Where is Echoliv headquartered?

Echoliv is headquartered in Paris, France.

When was Echoliv founded?

Echoliv was founded in 2021.

Which sector is Echoliv in?

Echoliv operates in Health Technology.

Who are Echoliv's competitors?

Companies similar to Echoliv include MadeCELL, ETISENSE, and Helpicto.